Denileukin diftitox Completed Phase 2 Trials for Leukemias / Systemic Mastocytosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00493129Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)